These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 33439397)
21. Long noncoding RNA SNHG14 promotes hepatocellular carcinoma progression by regulating miR-876-5p/SSR2 axis. Liao Z; Zhang H; Su C; Liu F; Liu Y; Song J; Zhu H; Fan Y; Zhang X; Dong W; Chen X; Liang H; Zhang B J Exp Clin Cancer Res; 2021 Jan; 40(1):36. PubMed ID: 33485374 [TBL] [Abstract][Full Text] [Related]
22. LncRNA HCG11 accelerates the progression of hepatocellular carcinoma via miR-26a-5p/ATG12 axis. Li ML; Zhang Y; Ma LT Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10708-10720. PubMed ID: 31858580 [TBL] [Abstract][Full Text] [Related]
23. MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma. Fang F; Chang RM; Yu L; Lei X; Xiao S; Yang H; Yang LY J Hepatol; 2015 Oct; 63(4):874-85. PubMed ID: 25998163 [TBL] [Abstract][Full Text] [Related]
24. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway. Li WF; Dai H; Ou Q; Zuo GQ; Liu CA Tumour Biol; 2016 May; 37(5):5885-95. PubMed ID: 26589417 [TBL] [Abstract][Full Text] [Related]
25. MiR-486-5p Suppresses Proliferation and Migration of Hepatocellular Carcinoma Cells through Downregulation of the E3 Ubiquitin Ligase CBL. He J; Xiao B; Li X; He Y; Li L; Sun Z Biomed Res Int; 2019; 2019():2732057. PubMed ID: 31976317 [TBL] [Abstract][Full Text] [Related]
26. Circ_0009910 promotes proliferation and metastasis of hepatocellular carcinoma cells through miR-335-5p/ROCK1 axis. Li HW; Liu J Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1725-1735. PubMed ID: 32141540 [TBL] [Abstract][Full Text] [Related]
27. RNF185-AS1 promotes hepatocellular carcinoma progression through targeting miR-221-5p/integrin β5 axis. Huang C; Li K; Huang R; Zhu J; Yang J Life Sci; 2021 Feb; 267():118928. PubMed ID: 33358902 [TBL] [Abstract][Full Text] [Related]
28. MicroRNA-361-5p Inhibits Tumorigenesis and the EMT of HCC by Targeting Twist1. Yin LC; Xiao G; Zhou R; Huang XP; Li NL; Tan CL; Xie FJ; Weng J; Liu LX Biomed Res Int; 2020; 2020():8891876. PubMed ID: 33381597 [TBL] [Abstract][Full Text] [Related]
29. MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737. Zhao G; Wang T; Huang QK; Pu M; Sun W; Zhang ZC; Ling R; Tao KS World J Gastroenterol; 2016 Jun; 22(23):5364-73. PubMed ID: 27340352 [TBL] [Abstract][Full Text] [Related]
30. XIST Induced by JPX Suppresses Hepatocellular Carcinoma by Sponging miR-155-5p. Lin XQ; Huang ZM; Chen X; Wu F; Wu W Yonsei Med J; 2018 Sep; 59(7):816-826. PubMed ID: 30091314 [TBL] [Abstract][Full Text] [Related]
31. DANCR contributed to hepatocellular carcinoma malignancy via sponging miR-216a-5p and modulating KLF12. Wang J; Pu J; Zhang Y; Yao T; Luo Z; Li W; Xu G; Liu J; Wei W; Deng Y J Cell Physiol; 2019 Jun; 234(6):9408-9416. PubMed ID: 30430564 [TBL] [Abstract][Full Text] [Related]
33. microRNA-93-5p promotes hepatocellular carcinoma progression via a microRNA-93-5p/MAP3K2/c-Jun positive feedback circuit. Shi X; Liu TT; Yu XN; Balakrishnan A; Zhu HR; Guo HY; Zhang GC; Bilegsaikhan E; Sun JL; Song GQ; Weng SQ; Dong L; Ott M; Zhu JM; Shen XZ Oncogene; 2020 Aug; 39(35):5768-5781. PubMed ID: 32719439 [TBL] [Abstract][Full Text] [Related]
34. Identification of MiR-211-5p as a tumor suppressor by targeting ACSL4 in Hepatocellular Carcinoma. Qin X; Zhang J; Lin Y; Sun XM; Zhang JN; Cheng ZQ J Transl Med; 2020 Aug; 18(1):326. PubMed ID: 32859232 [TBL] [Abstract][Full Text] [Related]
35. Circ_0003998 enhances doxorubicin resistance in hepatocellular carcinoma by regulating miR-218-5p/EIF5A2 pathway. Li X; He J; Ren X; Zhao H; Zhao H Diagn Pathol; 2020 Dec; 15(1):141. PubMed ID: 33308276 [TBL] [Abstract][Full Text] [Related]
36. circ-PRKCI targets miR-1294 and miR-186-5p by downregulating FOXK1 expression to suppress glycolysis in hepatocellular carcinoma. Chen W; Li Y; Zhong J; Wen G Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33880589 [TBL] [Abstract][Full Text] [Related]
37. miR-296-5p suppresses EMT of hepatocellular carcinoma via attenuating NRG1/ERBB2/ERBB3 signaling. Shi DM; Li LX; Bian XY; Shi XJ; Lu LL; Zhou HX; Pan TJ; Zhou J; Fan J; Wu WZ J Exp Clin Cancer Res; 2018 Nov; 37(1):294. PubMed ID: 30486894 [TBL] [Abstract][Full Text] [Related]
38. miR-584-5p regulates hepatocellular carcinoma cell migration and invasion through targeting KCNE2. Wei H; Wang J; Xu Z; Lu Y; Wu X; Zhuo C; Tan C; Tang Q; Pu J Mol Genet Genomic Med; 2019 Jun; 7(6):e702. PubMed ID: 31044566 [TBL] [Abstract][Full Text] [Related]
39. The tumor suppressor DLC1 inhibits cancer progression and oncogenic autophagy in hepatocellular carcinoma. Wu HT; Xie CR; Lv J; Qi HQ; Wang F; Zhang S; Fang QL; Wang FQ; Lu YY; Yin ZY Lab Invest; 2018 Aug; 98(8):1014-1024. PubMed ID: 29785050 [TBL] [Abstract][Full Text] [Related]
40. LncRNA CDKN2BAS predicts poor prognosis in patients with hepatocellular carcinoma and promotes metastasis via the miR-153-5p/ARHGAP18 signaling axis. Chen J; Huang X; Wang W; Xie H; Li J; Hu Z; Zheng Z; Li H; Teng L Aging (Albany NY); 2018 Nov; 10(11):3371-3381. PubMed ID: 30510148 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]